Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 18, Number 1—January 2012


Accelerating Control of Pertussis in England and Wales

Helen CampbellComments to Author , Gayatri Amirthalingam, Nick Andrews, Norman K. Fry, Robert C. George, Timothy G. Harrison, and Elizabeth Miller
Author affiliations: Health Protection Agency, London, UK

Main Article

Figure 1

Figure 1. Changes to routine childhood pertussis immunization programs and notifications of pertussis disease (all ages) and vaccine coverage among children <2 years of age, England and Wales, 1940–2009. DTwP, diphtheria/tetanus/whole-cell pertussis vaccine; DTaP3, diphtheria/tetanus/3-component acellular pertussis vaccine; DTaP5, diphtheria/tetanus/5-component aP vaccine; DTaP3-Hib, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b vaccine; DTaP3-Hib-IPV, diphtheria/tetanus/3-component acellular pertussis/Haemophilus influenzae type b/inactivated polio vaccine; DTaP3-IPV, diphtheria/tetanus/3-component acellular pertussis/inactivated polio vaccine; DTaP5-IPV, diphtheria/tetanus/5-component acellular pertussis/inactivated polio vaccine.

Main Article

Top of Page


Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order

CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You… The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO